Protein identified as potential drug target for pancreatic cancer

A protein known as arginine methyltransferase 1 (PRMT1) may be a potential therapeutic target for pancreatic ductal adenocarcinoma, the most common type of pancreatic cancer, according to a study by the Institute for Applied Cancer Science.Science Daily
Source: Society for Endocrinology - Category: Endocrinology Source Type: news